{
    "id": 28677,
    "fullName": "BST2 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "BST2 over exp indicates an over expression of the Bst2 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 684,
        "geneSymbol": "BST2",
        "terms": [
            "BST2",
            "CD317",
            "TETHERIN"
        ]
    },
    "variant": "over exp",
    "createDate": "09/24/2018",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15030,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, nasopharyngeal cancer cell lines overexpressing Bst2 were resistant to cisplatin, as demonstrated by apoptosis assays and gene knockdown experiments (PMID: 28617432).",
            "molecularProfile": {
                "id": 30562,
                "profileName": "BST2 over exp"
            },
            "therapy": {
                "id": 700,
                "therapyName": "Cisplatin",
                "synonyms": null
            },
            "indication": {
                "id": 9261,
                "name": "nasopharynx carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 12343,
                    "pubMedId": 28617432,
                    "title": "BST2 confers cisplatin resistance via NF-\u03baB signaling in nasopharyngeal cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28617432"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30562,
            "profileName": "BST2 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}